Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients

BACKGROUND: Tamoxifen is widely used as endocrine therapy for oestrogen-receptor-positive breast cancer. However, many of these patients experience recurrence despite tamoxifen therapy by incompletely understood mechanisms. In the present report we propose that tamoxifen resistance may be due to dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Wegman, Pia, Vainikka, Linda, Stål, Olle, Nordenskjöld, Bo, Skoog, Lambert, Rutqvist, Lars-Erik, Wingren, Sten
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1143572/
https://www.ncbi.nlm.nih.gov/pubmed/15987423
http://dx.doi.org/10.1186/bcr993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1143572/
https://www.ncbi.nlm.nih.gov/pubmed/15987423
http://dx.doi.org/10.1186/bcr993

Ejemplares similares